Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

A new AI model accurately detected cardiac amyloidosis from echocardiograms with higher accuracy vs. other amyloidosis risk ...

In a new study published in the European Heart Journal, researchers reported the successful development and validation of a ...

An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...

The AI model uses a single echocardiography videoclip to differentiate cardiac amyloidosis from other similar heart ...

An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

Researchers at the Federal University of São Carlos (UFSCar) in the state of São Paulo, Brazil, are developing a panel of ...

This statement seems to be based on the retraction of a high-profile paper, published in Nature in 2006, showing that amyloid ...

AA amyloidosis follows any number of inflammatory diseases, including classical rheumatologic diseases such as rheumatoid arthritis (RA), as well as "auto-inflammatory" conditions such as familiar ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June ...